# Nuclide record idea-reg-legacy-radium-recovery-ac225 (idea). Data CC BY-NC 4.0, attribute "Data from Nuclide (nuclide.cc)". Whole corpus: https://nuclide.cc/api/v1/nuclide.nt
@prefix schema: <https://schema.org/> .
@prefix nuclide: <https://nuclide.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://nuclide.cc/ideas/idea-reg-legacy-radium-recovery-ac225/>
  a schema:CreativeWork ;
  nuclide:kind "idea" ;
  schema:identifier "idea-reg-legacy-radium-recovery-ac225" ;
  schema:name "Recover legacy radium-226 sources worldwide as the feedstock for actinium-225"@en ;
  schema:description "Thousands of old radium sources sit in hospital and industrial storage. They are exactly the raw material needed to make actinium-225, the scarcest cancer isotope."@en ;
  schema:url <https://nuclide.cc/ideas/idea-reg-legacy-radium-recovery-ac225/> ;
  schema:dateModified "2026-09-08"^^xsd:date ;
  schema:citation <https://www.iaea.org/newscenter/news/actinium-225-production-and-supply> ;
  nuclide:related <https://nuclide.cc/isotopes/ac-225/> ;
  nuclide:technologies <https://nuclide.cc/technologies/targeted-alpha-therapy/>, <https://nuclide.cc/technologies/radioligand-therapy/> ;
  nuclide:drugs <https://nuclide.cc/drugs/ac225-psma/>, <https://nuclide.cc/drugs/ryz101/> ;
  nuclide:companies <https://nuclide.cc/companies/terrapower-isotopes/>, <https://nuclide.cc/companies/orano-med/> ;
  nuclide:bottlenecks <https://nuclide.cc/bottlenecks/b-manufacturing-cell-therapy/> .